Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis

Vaginal candidiasis is a common disease in women during their lifetime and occurs in diabetes patients, during pregnancy and oral contraceptives users. Although several antifungals are routinely used for treatment; however, vaginal candidiasis is a challenge for patients and gynecologists. The aim of the present study was to evaluate terbinafme [Lamisil] on Candida vaginitis versus clotrimazole. In the present study women suspected to have vulvovaginal candidiasis were sampled and disease confirmed using direct smear and culture examination from vaginal discharge. Then, patients were randomly divided into two groups, the first group [32 cases] was treated with clotrimazole and the next [25 cases] with Lamisil. All patients were followed-up to three weeks of treatment and therapeutic effects of both antifungal were compared. Our results shows that 12 [37.5%] patients were completely treated with clotrimazole during two weeks and, 6[18.8%] patients did not respond to drugs and were refereed for fluconazole therapy. Fourteen [43.8%] patients showed moderate response and clotrimazole therapy was extended for one more week. When Lamisil was administrated, 19 [76.0%] patients were completely treated with Lamisil in two weeks, and 1 [4.0%] of the patients did not respond to the drug and was refereed for fluconazole therapy. Five [20.0%] of our patients showed moderate response and Lamisil therapy was extended for one more week. Our results show that vaginal cream, 1% Lamisil, could be suggested as a first-line treatment in vulvovaginal candidiasis

Clinical study of candida vaginitis in Ahvaz, Iran and susceptibility of agents to topical antifungal

To evaluate etiological agents of vaginal candidiasis in Ahvaz, Iran. In addition, susceptibility isolates were also considered against topical anti fungal agents. Cotton swabs were used for sampling from vaginal lesions and inoculated on CHRO Magar Candida. Cultured media were incubated at 37°C for 2-4 days aerobically. Colonies producing a green coloration were presumptively identified as Candida. albicans. C. glabrata produced pink colonies on CHRO Magar Candida. One hundred vaginal isolates of Candida were sub-cultured on SDA and incubated at 37°C. A suspension of isolates containing 1x106 - 5x106 cfu/ml was used for susceptibility tests. Clotrimazole, miconazole and nystatin disks were used for determine of susceptibility. Prevalence of Candida among the 300 women enrolled was found to be 49%. Recurrent and acute vaginal candidiasis were 48.3% and 51.7% respectively. C. albicans was the most common species among the isolates followed by C. glabrata, C. dubliniensis and Candida species. Antifungal susceptibility testing in our study revealed that none of the Candida isolates tested were resistant to tested antifungal. However, isolates were susceptible to clotrimazole followed by miconazole and nystatin. Candida vaginitis is more prevalent among women in Ahvaz and the most common agent is C. albicans. In addition our isolates were sensitive to clotrimazole followed by miconazole and nystatin